Sigma Healthcare revenue and financials
$2.64Change from previous close: +0.76%Absolute change: +$0.02
In the fiscal year ended June 2026, Sigma Healthcare reported revenue of $10.83B (+80.53% year over year). Net income was $709.18M, a net margin of 6.5%.
Fiscal year ending in June. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +80.53%
- FY to Jun 2026 vs FY to Jun 2025
- Net income growth
- +33.83%
- FY to Jun 2026 vs FY to Jun 2025
- Net margin
- 6.5%
- FY to Jun 2025: 8.8%
Financial data
Amounts in millions of AUD; per-share values in AUD; shares in millions.
| Item | FY to Jun 2026 | FY to Jun 2025 | FY to Jan 2025 | FY to Jan 2024 | FY to Jan 2023 | FY to Jan 2022 |
|---|---|---|---|---|---|---|
| Operating cash flow | 575 | 599 | — | — | — | — |
| Depreciation and amortization | 85.0 | 56.0 | — | — | — | — |
| Capital expenditure | -56.7 | -57.6 | -7.9 | -4.7 | — | — |
| Investing cash flow | 62.6 | 266 | -1.6 | 5.7 | — | — |
| Financing cash flow | -645 | -1,001 | -24.7 | 296 | — | — |
| Dividends paid | -379 | -1,186 | -17.1 | -10.8 | — | — |
| Share repurchases | — | -6.4 | — | — | — | — |
| Debt issued | 5,488 | 3,003 | 400 | 725 | — | — |
| Debt repaid | -5,593 | -2,679 | -400 | -805 | — | — |
| Effect of exchange rates | 0.3 | 1.5 | -0.0 | 0.0 | — | — |
| Net change in cash | -7.9 | -136 | -342 | 344 | — | — |
| Free cash flow | 518 | 541 | -324 | 37.2 | — | — |
| Levered free cash flow | 391 | -217 | — | — | — | — |